Product NDC: | 60055-647 |
Proprietary Name: | Fludeoxyglucose F 18 |
Non Proprietary Name: | Fludeoxyglucose F-18 |
Active Ingredient(s): | 475 mCi/mL & nbsp; Fludeoxyglucose F-18 |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60055-647 |
Labeler Name: | Triad Isotopes, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20101120 |
Package NDC: | 60055-647-10 |
Package Description: | 10 mL in 1 VIAL (60055-647-10) |
NDC Code | 60055-647-10 |
Proprietary Name | Fludeoxyglucose F 18 |
Package Description | 10 mL in 1 VIAL (60055-647-10) |
Product NDC | 60055-647 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Fludeoxyglucose F-18 |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20101120 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | Triad Isotopes, Inc. |
Substance Name | FLUDEOXYGLUCOSE F-18 |
Strength Number | 475 |
Strength Unit | mCi/mL |
Pharmaceutical Classes | Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA] |